0001144204-12-040012.txt : 20120718 0001144204-12-040012.hdr.sgml : 20120718 20120718164929 ACCESSION NUMBER: 0001144204-12-040012 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120718 DATE AS OF CHANGE: 20120718 EFFECTIVENESS DATE: 20120718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CURE PHARMACEUTICAL Corp CENTRAL INDEX KEY: 0001554289 IRS NUMBER: 452717791 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-181465 FILM NUMBER: 12968309 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805 824 0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 D 1 primary_doc.xml X0706 D LIVE 0001554289 CURE PHARMACEUTICAL Corp 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 805 824 0410 CALIFORNIA None None Corporation true 2011 Robert Davidson 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 Executive Officer Director Edward Maliski 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 Executive Officer Director Mark Udell 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 Executive Officer Wayne Nasby 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 Executive Officer Director Jonathan Turman 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 Executive Officer Director Vic Branstetter 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 Director Manufacturing $1,000,001 - $5,000,000 06 false 2012-07-10 false true true false 15000 958568 958568 0 false 12 0 0 958568 Consideration paid was in the form of Secured Promissory Notes. false CURE PHARMACEUTICAL Corp /s/ Mark Udell Mark Udell Chief Financial Officer 2012-07-18